Medical treatments are typically designed for the “average patient”. This “one-size-fits-all” approach often results in treatments being successful for some patients but not for others. The emergence of precision medicine aims to change this, by taking into account individual differences in people’s underlying biological characteristics. Precision medicine gives healthcare practitioners better tools to improve understandings of complex mechanisms underlying a patient’s health or disease, and to better predict which treatments will be most effective.
The technology underlying the InsightRX platform incorporates the principles of quantitative pharmacology and machine learning to provide an individualized understanding of a patient’s response to treatment. Quantitative pharmacology describes in mathematical and statistical language the relationship(s) between disease, drug action, and individual variability, which enables patient specific quantitative decision-making. The InsightRX platform delivers this technology in the form of easy to use clinical decision support tools at the point of care to help guide treatment decision-making.
The InsightRX platform guides treatment decisions at both the individual level and the population level. At the individual level, drug concentration and biomarker data are collected over-time to learn about the patient response and optimize treatment. At the population level, as more data is collected in larger patient populations, or in infrequently encountered patient populations, our pharmacological models and clinical algorithms that guide treatment recommendations will learn and will become more precise.
Learn more at http://www.insight-rx.com/.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $12.8M
Founded date: 2015
Investors 11
Show more
Funding Rounds 1
Date | Series | Amount | Investors |
19.09.2019 | Series A | $10M | - |
Mentions in press and media 18
Date | Title | Description | Source |
25.02.2024 | InsightRX Receives Growth Financing | InsightRX, a San Francisco, CA-based software company leveraging quantitative pharmacology and artif... | finsmes.co... |
05.08.2021 | InsightRX Receives CE Mark for Nova Software, Allowing it to... | prnewswire... | |
21.12.2020 | InsightRX Adds Renowned Pharmacology Experts Drs. Richard Pe... | prnewswire... | |
21.09.2020 | Corporate Startup Agility: A Look at How OSF Health Care Tea... | When considering innovation, OSF HealthCare has consistently maintained a focus of “What do we nee... | masschalle... |
23.09.2019 | Daily funding roundup - September 23rd, 2019 | Landline raised $3.85M; InsightRX landed $10M; Immutable closed $15M; Kheiron picksup $22M Landline:... | vator.tv/n... |
20.09.2019 | InsightRX Raises $10M in Series A | SAN FRANCISCO, CA, Pioneer in precision medicine, announced today the closing of its $10 million S... | vcnewsdail... |
19.09.2019 | Precision dosing platform InsightRX raises $10M | The company partners with both hospitals and pharma companies to personalize medications According t... | vator.tv/n... |
19.09.2019 | Daily funding roundup - September 19th, 2019 | Red Sift closed $8.8M; Robin Healthcare raised $11.5M; Tethr landed $15M; Versantis picks up $16M Ne... | vator.tv/n... |
19.09.2019 | InsightRX Lands $10M for Precision Medicine Dosing at the Po... | – InsightRX raises $10M led by HealthX Ventures to accelerate the adoption of its precision dosing a... | hitconsult... |
19.09.2019 | Precision medication dosing tool InsightRX closes $10M | mobihealth... |
Show more